These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34055788)

  • 1. Differentiation and Application of Human Pluripotent Stem Cells Derived Cardiovascular Cells for Treatment of Heart Diseases: Promises and Challenges.
    Gao Y; Pu J
    Front Cell Dev Biol; 2021; 9():658088. PubMed ID: 34055788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
    Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart regeneration with human pluripotent stem cells: Prospects and challenges.
    Jiang Y; Lian XL
    Bioact Mater; 2020 Mar; 5(1):74-81. PubMed ID: 31989061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes.
    Le MNT; Hasegawa K
    Bioengineering (Basel); 2019 May; 6(2):. PubMed ID: 31137703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Park M; Yoon YS
    Korean Circ J; 2018 Nov; 48(11):974-988. PubMed ID: 30334384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy.
    Silver SE; Barrs RW; Mei Y
    Front Cardiovasc Med; 2021; 8():707890. PubMed ID: 34820426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
    Ban K; Bae S; Yoon YS
    Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Genetic and Epigenetic Regulation of Cardiac Differentiation from Human Pluripotent Stem Cells.
    Fujita J; Tohyama S; Kishino Y; Okada M; Morita Y
    Stem Cells; 2019 Aug; 37(8):992-1002. PubMed ID: 31021504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of Human Pluripotent Stem Cell-Derived Cardiac Lineages.
    Skelton RJP; Kamp TJ; Elliott DA; Ardehali R
    Trends Mol Med; 2017 Jul; 23(7):651-668. PubMed ID: 28576602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Regeneration via Stem Cells and Direct Reprogramming: A Review.
    Lee CS; Kim J; Cho HJ; Kim HS
    Korean Circ J; 2022 May; 52(5):341-353. PubMed ID: 35502566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells.
    Liu S; Xu Y; Zhou Z; Feng B; Huang H
    Cytotherapy; 2015 Apr; 17(4):344-58. PubMed ID: 25680303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Human Pluripotent Stem Cells Into Specific Neural Lineages.
    Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Harn HJ; Lin SZ; Ho TJ
    Cell Transplant; 2021; 30():9636897211017829. PubMed ID: 34665040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell-derived clonally expanded mesenchymal progenitor cells from somatic cell nuclear transfer-derived pluripotent stem cells ameliorate the endometrial function in the uterus of a murine model with Asherman's syndrome.
    Jun SM; Park M; Lee JY; Jung S; Lee JE; Shim SH; Song H; Lee DR
    Cell Prolif; 2019 May; 52(3):e12597. PubMed ID: 30896075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural Differentiation of Human Pluripotent Stem Cells for Nontherapeutic Applications: Toxicology, Pharmacology, and In Vitro Disease Modeling.
    Yap MS; Nathan KR; Yeo Y; Lim LW; Poh CL; Richards M; Lim WL; Othman I; Heng BC
    Stem Cells Int; 2015; 2015():105172. PubMed ID: 26089911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-scale purification of pluripotent stem cell derivatives for cell-based therapies.
    Rodrigues GM; Rodrigues CA; Fernandes TG; Diogo MM; Cabral JM
    Biotechnol J; 2015 Aug; 10(8):1103-14. PubMed ID: 25851544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.
    Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK
    Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.